Andere talen Sumitomo Pharma Co., Ltd.

Aandelen

4506

JP3495000006

Vertraagde tijd Japan Exchange Andere beurzen 04:15:39 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
392 ^JPY	-1,75%		-4,16%	-15,88%

22/04	Luwte in geopolitieke spanningen tilt Aziatische aandelenmarkten op	MT
17/04	SUMITOMO PHARMA CO., LTD. : Jefferies & Co. blijft neutraal	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sumitomo Pharma : Presentation Material (Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024)	30/04
Poxel : reporte la publication de ses résultats annuels 2023	29/04
Lull in Geopolitical Tensions Lifts Asian Stock Markets	22/04
Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	02/04
Roivant's anti-inflammatory drug succeeds in mid-stage study	02/04
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18/03
Sumitomo Pharma Co., Ltd.(TSE:4506) dropped from S&P Japan 500	18/03
Sumitomo Pharma : Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	15/03
Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	15/03
Sumitomo Pharma Announces Availability of ORGOVYX in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer	13/03
US Inflation Report Lifts Asian Stock Markets	01/03
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02
Japan's Nikkei slips after Fed chair signals delay in rate cut	01/02
Sumitomo Pharma Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	31/01
Sumitomo Pharma Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	31/01
Fed, China Property Outlooks Roil Asian Stock Markets	30/01
Poxel Announces its Financial Calendar for 2024	04/01
Japan's Nikkei rounds off 2023 with biggest yearly gain in a decade	29/12
Sumitomo Pharma : Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson’s Disease in the United States	26/12
Poxel Provides Corporate Update	22/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sumitomo Pharma Co., Ltd.

Aandelen

4506

JP3495000006

Andere talen

Filters